Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
fda
novartis
gene editing
gene therapy
johnson & johnson
medical devices
medicare
merck
pfizer
vc
What
bio
roundup
gene
ipo
life
science
allogene
alzheimer’s
august
becker
billions
biopharma
biotech
biotechs
busy
cancer
car
celgene
chose
close
colleagues
companies
company
crispr
days
decisions
device
devices
different
diversity
dollars
drug
drugs
eaton
exome
fail
fda
firms
government
health
Language
unset
Current search:
celgene
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
